nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Duloxetine—HTR6—Alzheimer's disease	0.0158	0.338	CrCbGaD
Naphazoline—Hyperglycaemia—Galantamine—Alzheimer's disease	0.0157	0.0328	CcSEcCtD
Naphazoline—Eye pain—Memantine—Alzheimer's disease	0.0157	0.0328	CcSEcCtD
Naphazoline—Eye pain—Rivastigmine—Alzheimer's disease	0.0154	0.0321	CcSEcCtD
Naphazoline—Eye disorder—Galantamine—Alzheimer's disease	0.0131	0.0272	CcSEcCtD
Naphazoline—Hyperglycaemia—Donepezil—Alzheimer's disease	0.0122	0.0254	CcSEcCtD
Naphazoline—Tension—Galantamine—Alzheimer's disease	0.0119	0.0249	CcSEcCtD
Naphazoline—Nervousness—Galantamine—Alzheimer's disease	0.0118	0.0246	CcSEcCtD
Naphazoline—Sweating—Donepezil—Alzheimer's disease	0.0116	0.0241	CcSEcCtD
Naphazoline—Vision blurred—Galantamine—Alzheimer's disease	0.0115	0.0239	CcSEcCtD
Naphazoline—Hyperglycaemia—Memantine—Alzheimer's disease	0.0111	0.0231	CcSEcCtD
Naphazoline—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.0108	0.0226	CcSEcCtD
Naphazoline—Drowsiness—Rivastigmine—Alzheimer's disease	0.0107	0.0223	CcSEcCtD
Naphazoline—Hypertension—Galantamine—Alzheimer's disease	0.0105	0.0219	CcSEcCtD
Naphazoline—Sweating—Rivastigmine—Alzheimer's disease	0.0103	0.0214	CcSEcCtD
Naphazoline—Discomfort—Galantamine—Alzheimer's disease	0.0102	0.0213	CcSEcCtD
Naphazoline—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00959	0.02	CcSEcCtD
Naphazoline—Erythema—Donepezil—Alzheimer's disease	0.00942	0.0196	CcSEcCtD
Naphazoline—Tension—Donepezil—Alzheimer's disease	0.00925	0.0193	CcSEcCtD
Naphazoline—Eye disorder—Memantine—Alzheimer's disease	0.00918	0.0191	CcSEcCtD
Naphazoline—Nervousness—Donepezil—Alzheimer's disease	0.00915	0.0191	CcSEcCtD
Naphazoline—Eye disorder—Rivastigmine—Alzheimer's disease	0.00898	0.0187	CcSEcCtD
Naphazoline—Vision blurred—Donepezil—Alzheimer's disease	0.00888	0.0185	CcSEcCtD
Naphazoline—Somnolence—Galantamine—Alzheimer's disease	0.00882	0.0184	CcSEcCtD
Naphazoline—Tension—Memantine—Alzheimer's disease	0.0084	0.0175	CcSEcCtD
Naphazoline—Erythema—Rivastigmine—Alzheimer's disease	0.00837	0.0174	CcSEcCtD
Naphazoline—Nervousness—Memantine—Alzheimer's disease	0.00831	0.0173	CcSEcCtD
Naphazoline—Terbinafine—PTGS1—Alzheimer's disease	0.00829	0.177	CrCbGaD
Naphazoline—Tension—Rivastigmine—Alzheimer's disease	0.00821	0.0171	CcSEcCtD
Naphazoline—Hypertension—Donepezil—Alzheimer's disease	0.00813	0.017	CcSEcCtD
Naphazoline—Nervousness—Rivastigmine—Alzheimer's disease	0.00813	0.0169	CcSEcCtD
Naphazoline—Vision blurred—Memantine—Alzheimer's disease	0.00806	0.0168	CcSEcCtD
Naphazoline—Discomfort—Donepezil—Alzheimer's disease	0.00793	0.0165	CcSEcCtD
Naphazoline—Vision blurred—Rivastigmine—Alzheimer's disease	0.00789	0.0164	CcSEcCtD
Naphazoline—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00743	0.0155	CcSEcCtD
Naphazoline—Hypertension—Memantine—Alzheimer's disease	0.00739	0.0154	CcSEcCtD
Naphazoline—Hypertension—Rivastigmine—Alzheimer's disease	0.00723	0.0151	CcSEcCtD
Naphazoline—Discomfort—Memantine—Alzheimer's disease	0.0072	0.015	CcSEcCtD
Naphazoline—Asthenia—Galantamine—Alzheimer's disease	0.00712	0.0148	CcSEcCtD
Naphazoline—Discomfort—Rivastigmine—Alzheimer's disease	0.00704	0.0147	CcSEcCtD
Naphazoline—Somnolence—Donepezil—Alzheimer's disease	0.00684	0.0143	CcSEcCtD
Naphazoline—Hyperhidrosis—Memantine—Alzheimer's disease	0.00675	0.0141	CcSEcCtD
Naphazoline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.0066	0.0138	CcSEcCtD
Naphazoline—Dizziness—Galantamine—Alzheimer's disease	0.00656	0.0137	CcSEcCtD
Naphazoline—Headache—Galantamine—Alzheimer's disease	0.00622	0.013	CcSEcCtD
Naphazoline—Somnolence—Memantine—Alzheimer's disease	0.00621	0.0129	CcSEcCtD
Naphazoline—Somnolence—Rivastigmine—Alzheimer's disease	0.00607	0.0127	CcSEcCtD
Naphazoline—Duloxetine—SLC6A4—Alzheimer's disease	0.00606	0.129	CrCbGaD
Naphazoline—Nausea—Galantamine—Alzheimer's disease	0.00589	0.0123	CcSEcCtD
Naphazoline—Terbinafine—CYP2D6—Alzheimer's disease	0.00564	0.12	CrCbGaD
Naphazoline—Asthenia—Donepezil—Alzheimer's disease	0.00552	0.0115	CcSEcCtD
Naphazoline—Dizziness—Donepezil—Alzheimer's disease	0.00509	0.0106	CcSEcCtD
Naphazoline—Asthenia—Memantine—Alzheimer's disease	0.00501	0.0104	CcSEcCtD
Naphazoline—Asthenia—Rivastigmine—Alzheimer's disease	0.0049	0.0102	CcSEcCtD
Naphazoline—Headache—Donepezil—Alzheimer's disease	0.00482	0.01	CcSEcCtD
Naphazoline—Duloxetine—HTR2A—Alzheimer's disease	0.00465	0.0994	CrCbGaD
Naphazoline—Dizziness—Memantine—Alzheimer's disease	0.00462	0.00963	CcSEcCtD
Naphazoline—Nausea—Donepezil—Alzheimer's disease	0.00457	0.00952	CcSEcCtD
Naphazoline—Dizziness—Rivastigmine—Alzheimer's disease	0.00452	0.00942	CcSEcCtD
Naphazoline—Headache—Memantine—Alzheimer's disease	0.00437	0.00912	CcSEcCtD
Naphazoline—Headache—Rivastigmine—Alzheimer's disease	0.00428	0.00892	CcSEcCtD
Naphazoline—Duloxetine—CYP2D6—Alzheimer's disease	0.00426	0.0909	CrCbGaD
Naphazoline—Nausea—Memantine—Alzheimer's disease	0.00415	0.00865	CcSEcCtD
Naphazoline—Nausea—Rivastigmine—Alzheimer's disease	0.00406	0.00846	CcSEcCtD
Naphazoline—Propranolol—CYP2D6—Alzheimer's disease	0.00212	0.0452	CrCbGaD
Naphazoline—ADRA2C—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000191	0.000404	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CALM1—Alzheimer's disease	0.000191	0.000404	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ABCA1—Alzheimer's disease	0.000191	0.000404	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GSK3A—Alzheimer's disease	0.00019	0.000402	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—NOS3—Alzheimer's disease	0.000189	0.000398	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000188	0.000398	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NPS—Alzheimer's disease	0.000188	0.000397	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—A2M—Alzheimer's disease	0.000187	0.000396	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APP—Alzheimer's disease	0.000187	0.000395	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000187	0.000395	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—F2—Alzheimer's disease	0.000185	0.00039	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000185	0.00039	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PTK2B—Alzheimer's disease	0.000184	0.000389	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000184	0.000389	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS1—Alzheimer's disease	0.000183	0.000386	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ENO1—Alzheimer's disease	0.000183	0.000386	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000181	0.000383	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.00018	0.000381	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—F2—Alzheimer's disease	0.00018	0.000379	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NPY—Alzheimer's disease	0.00018	0.000379	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GAB2—Alzheimer's disease	0.000179	0.000379	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NTRK2—Alzheimer's disease	0.000179	0.000379	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SST—Alzheimer's disease	0.000179	0.000379	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—VEGFA—Alzheimer's disease	0.000179	0.000378	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CYP2D6—Alzheimer's disease	0.000179	0.000378	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CALM1—Alzheimer's disease	0.000179	0.000377	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IAPP—Alzheimer's disease	0.000179	0.000377	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GSK3A—Alzheimer's disease	0.000178	0.000375	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PLCB1—Alzheimer's disease	0.000177	0.000373	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000175	0.000369	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APP—Alzheimer's disease	0.000175	0.000369	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CRH—Alzheimer's disease	0.000173	0.000366	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000171	0.000362	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000171	0.000361	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—BCHE—Alzheimer's disease	0.00017	0.000358	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	0.000168	0.000355	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—F2—Alzheimer's disease	0.000168	0.000354	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000168	0.000354	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—VEGFA—Alzheimer's disease	0.000167	0.000353	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000167	0.000353	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NPY—Alzheimer's disease	0.000167	0.000353	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IAPP—Alzheimer's disease	0.000166	0.00035	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PLCB1—Alzheimer's disease	0.000165	0.000348	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPARGC1A—Alzheimer's disease	0.000165	0.000348	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NGFR—Alzheimer's disease	0.000165	0.000348	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TGFB1—Alzheimer's disease	0.000164	0.000347	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NPS—Alzheimer's disease	0.000164	0.000347	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—HMOX1—Alzheimer's disease	0.000164	0.000346	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CREB1—Alzheimer's disease	0.000164	0.000346	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000163	0.000345	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—F2—Alzheimer's disease	0.000162	0.000341	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000161	0.00034	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CRH—Alzheimer's disease	0.000161	0.00034	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ADAM10—Alzheimer's disease	0.000161	0.00034	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PLCB1—Alzheimer's disease	0.00016	0.000338	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CCL2—Alzheimer's disease	0.00016	0.000338	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000159	0.000336	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SST—Alzheimer's disease	0.000157	0.000331	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GAB2—Alzheimer's disease	0.000157	0.000331	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000157	0.000331	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000156	0.00033	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000155	0.000328	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000155	0.000328	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	0.000155	0.000328	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NGFR—Alzheimer's disease	0.000154	0.000325	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TGFB1—Alzheimer's disease	0.000154	0.000324	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CREB1—Alzheimer's disease	0.000153	0.000323	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APP—Alzheimer's disease	0.000153	0.000323	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	0.000153	0.000322	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—S100B—Alzheimer's disease	0.000152	0.000321	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000152	0.000321	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ADAM10—Alzheimer's disease	0.00015	0.000317	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	0.00015	0.000317	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—LPL—Alzheimer's disease	0.00015	0.000317	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	0.00015	0.000316	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CCL2—Alzheimer's disease	0.00015	0.000316	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—F2—Alzheimer's disease	0.000147	0.00031	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000146	0.000308	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	0.000146	0.000308	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	0.000146	0.000308	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000145	0.000306	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF2—Alzheimer's disease	0.000145	0.000306	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000144	0.000305	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000144	0.000304	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—S100B—Alzheimer's disease	0.000142	0.0003	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	0.000142	0.0003	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF1R—Alzheimer's disease	0.00014	0.000296	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	0.000136	0.000288	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	0.000136	0.000287	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TP53—Alzheimer's disease	0.000135	0.000286	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF2—Alzheimer's disease	0.000135	0.000286	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—MTHFR—Alzheimer's disease	0.000135	0.000285	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NGFR—Alzheimer's disease	0.000134	0.000284	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LPL—Alzheimer's disease	0.000134	0.000284	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000134	0.000283	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	0.000134	0.000283	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000134	0.000282	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	0.000133	0.000281	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MEF2C—Alzheimer's disease	0.000133	0.000281	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000131	0.000277	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF1R—Alzheimer's disease	0.000131	0.000276	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000131	0.000276	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PRKCG—Alzheimer's disease	0.000131	0.000276	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NGF—Alzheimer's disease	0.000127	0.000269	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TP53—Alzheimer's disease	0.000126	0.000267	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CALM1—Alzheimer's disease	0.000126	0.000266	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—APOE—Alzheimer's disease	0.000126	0.000265	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LPL—Alzheimer's disease	0.000125	0.000265	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	0.000125	0.000264	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	0.000125	0.000263	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CAV1—Alzheimer's disease	0.000125	0.000263	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MEF2C—Alzheimer's disease	0.000124	0.000262	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—S100B—Alzheimer's disease	0.000124	0.000262	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000124	0.000262	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCR5—Alzheimer's disease	0.000124	0.000261	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	0.000122	0.000258	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PRKCG—Alzheimer's disease	0.000122	0.000258	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—LPL—Alzheimer's disease	0.000122	0.000257	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000121	0.000257	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HTR2A—Alzheimer's disease	0.000121	0.000256	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NGF—Alzheimer's disease	0.000119	0.000251	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF2—Alzheimer's disease	0.000118	0.00025	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCR5—Alzheimer's disease	0.000116	0.000244	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	0.000115	0.000244	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000114	0.000241	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—AKT1—Alzheimer's disease	0.000114	0.000241	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR2A—Alzheimer's disease	0.000113	0.000239	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CALM1—Alzheimer's disease	0.000113	0.000238	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LEP—Alzheimer's disease	0.000113	0.000238	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOE—Alzheimer's disease	0.000113	0.000238	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CAV1—Alzheimer's disease	0.000112	0.000235	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	0.00011	0.000232	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	0.00011	0.000232	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LPL—Alzheimer's disease	0.00011	0.000232	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPARG—Alzheimer's disease	0.00011	0.000231	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000109	0.000229	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ESR1—Alzheimer's disease	0.000107	0.000227	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—INS—Alzheimer's disease	0.000107	0.000227	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—AKT1—Alzheimer's disease	0.000107	0.000226	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000107	0.000225	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000106	0.000224	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—F2—Alzheimer's disease	0.000106	0.000224	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CALM1—Alzheimer's disease	0.000105	0.000223	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	0.000105	0.000222	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LEP—Alzheimer's disease	0.000105	0.000222	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	0.000104	0.00022	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000104	0.000219	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NGF—Alzheimer's disease	0.000104	0.000219	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TP53—Alzheimer's disease	0.000103	0.000217	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CALM1—Alzheimer's disease	0.000102	0.000216	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOE—Alzheimer's disease	0.000102	0.000216	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	0.000102	0.000215	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CAV1—Alzheimer's disease	0.000101	0.000214	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCR5—Alzheimer's disease	0.000101	0.000213	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000101	0.000213	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	0.0001	0.000212	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	9.91e-05	0.000209	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	9.9e-05	0.000209	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR2A—Alzheimer's disease	9.88e-05	0.000209	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	9.75e-05	0.000206	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	9.7e-05	0.000205	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	9.67e-05	0.000204	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	9.65e-05	0.000204	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	9.61e-05	0.000203	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	9.46e-05	0.0002	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—NOS3—Alzheimer's disease	9.42e-05	0.000199	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	9.39e-05	0.000198	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	9.3e-05	0.000196	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	9.22e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	9.19e-05	0.000194	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	9.19e-05	0.000194	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	9.18e-05	0.000194	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	9.1e-05	0.000192	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	9.1e-05	0.000192	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	9.03e-05	0.000191	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	8.98e-05	0.00019	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARG—Alzheimer's disease	8.89e-05	0.000188	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	8.84e-05	0.000187	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	8.77e-05	0.000185	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—INS—Alzheimer's disease	8.72e-05	0.000184	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	8.69e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	8.67e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	8.67e-05	0.000183	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	8.61e-05	0.000182	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	8.57e-05	0.000181	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	8.54e-05	0.00018	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	8.54e-05	0.00018	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	8.48e-05	0.000179	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	8.46e-05	0.000179	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	8.43e-05	0.000178	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	8.15e-05	0.000172	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	8.05e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	7.96e-05	0.000168	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	7.89e-05	0.000167	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	7.88e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	7.88e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	7.85e-05	0.000166	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	7.72e-05	0.000163	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NOS3—Alzheimer's disease	7.65e-05	0.000162	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	7.59e-05	0.00016	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	7.39e-05	0.000156	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	7.33e-05	0.000155	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	7.29e-05	0.000154	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	7.22e-05	0.000153	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	7.18e-05	0.000152	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	7.16e-05	0.000151	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	7.11e-05	0.00015	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	7.06e-05	0.000149	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	7e-05	0.000148	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	6.88e-05	0.000145	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	6.75e-05	0.000143	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	6.69e-05	0.000141	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	6.64e-05	0.00014	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	6.58e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	6.56e-05	0.000139	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	6.4e-05	0.000135	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	6.14e-05	0.00013	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	6.13e-05	0.000129	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	6.07e-05	0.000128	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.9e-05	0.000125	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	5.84e-05	0.000123	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	5.81e-05	0.000123	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	5.67e-05	0.00012	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	5.57e-05	0.000118	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	5.48e-05	0.000116	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	5.43e-05	0.000115	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	5.4e-05	0.000114	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	5.37e-05	0.000113	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	5.36e-05	0.000113	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	5.21e-05	0.00011	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	4.99e-05	0.000105	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	4.98e-05	0.000105	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	4.96e-05	0.000105	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	4.61e-05	9.73e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	4.59e-05	9.69e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	4.55e-05	9.61e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AKT1—Alzheimer's disease	4.33e-05	9.14e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	4.29e-05	9.05e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	4.23e-05	8.93e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	4.2e-05	8.87e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	3.92e-05	8.29e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	3.88e-05	8.18e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	3.75e-05	7.91e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	3.62e-05	7.65e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AKT1—Alzheimer's disease	3.52e-05	7.43e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	3.48e-05	7.35e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	3.43e-05	7.24e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	3.19e-05	6.73e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	3.16e-05	6.68e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	2.94e-05	6.21e-05	CbGpPWpGaD
